Lupin Expands Europe Access to YUVEZZI Presbyopia Therapy
Mumbai, India; Amsterdam, Netherlands; London, UK; Naples, Florida; Warren, New Jersey, August 20, 2026 Lupin Limited and Tenpoint Therapeutics...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Mumbai, India; Amsterdam, Netherlands; London, UK; Naples, Florida; Warren, New Jersey, August 20, 2026 Lupin Limited and Tenpoint Therapeutics...
Vancouver, British Columbia, August 20, 2026 Avricore Health Inc. has announced that its wholly owned subsidiary, HealthTab Ltd., has...
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
